Purlin Pharma Private Limited
About Purlin Pharma Private Limited
Data last updated:
Purlin Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2016PTC040720. Its GSTIN is 23AAICP5863F1ZC (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gaurav Bagga and Falak Bagga.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.25 Lakh, a decline of 47% compared to the previous year. For the same year it recorded a net loss of ₹2,155 (net margin -0.7%) and EBITDA of ₹5,098 (EBITDA margin 1.6%). Revenue has declined at a compounded annual rate (CAGR) of 59% over three years and 46% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address307 Princes Business Sky Line Block 32&33 Scheme No. 54 Vijay Nagar, A.B. Road, Indore, Madhya Pradesh, India – 452010
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Purlin Pharma Private Limited
The main business activity of Purlin Pharma is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Purlin Pharma Private Limited FY 2024 filings available
Purlin Pharma Private Limited reported revenue of ₹3.25 Lakh (down 47% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Purlin Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 46% over five years, including a 47% fall in the latest year. EBITDA rose 101% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Purlin Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5,098 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2,155 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Purlin Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Purlin Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Purlin Pharma Private Limited
Purlin Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Medical and dental practice, Nursing, pathology, blood bank services, etc.). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr. Kpr's Labs Private Limited | ₹3.42 Lakh (FY 2021) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Audiunt Hearing Solution Private Limited | ₹3.33 Lakh (FY 2020) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Sumati Diagnostics Private Limited | ₹3.32 Lakh (FY 2025) | •••• | •••• | 46.0% | •••• | Pune, Maharashtra, India |
| Oreal Healthcare & Wellness Private Limited | ₹3.3 Lakh (FY 2025) | •••• | •••• | 1199.0% | •••• | Delhi, India |
| Medi One Pharma Labs Private Limited | ₹3.26 Lakh (FY 2021) | •••• | •••• | -32.0% | •••• | Chennai, Tamil Nadu, India |
| Purlin Pharma Private Limited this company | ₹3.25 Lakh (FY 2024) | •••• | •••• | -47.0% | •••• | Indore, Madhya Pradesh, India |
| Creasta Pharmaceuticals Private Limited | ₹3.23 Lakh (FY 2024) | •••• | •••• | 125.0% | •••• | Coimbatore, Tamil Nadu, India |
| Ananya Lab Private Limited | ₹3.2 Lakh (FY 2025) | •••• | •••• | 12.0% | •••• | Patna, Bihar, India |
| Matushree Nursing Home Pvt Ltd | ₹3.12 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | Indore, Madhya Pradesh, India |
| Patan Diagnostic and Research Private Limited | ₹3.11 Lakh (FY 2017) | •••• | •••• | -74.0% | •••• | Gujarat, India |
| Pathcore Diagnostics Private Limited | ₹3.09 Lakh (FY 2024) | •••• | •••• | 561.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Purlin Pharma by revenue in the same principal business activity (Medical and dental practice, Nursing, pathology, blood bank services, etc.), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Purlin Pharma Private Limited
Purlin Pharma Private Limited is audited by J P SARAF & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J P SARAF & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Purlin Pharma Private Limited
Purlin Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Bagga Also directs: F G S Buildtech LLP | Director | 09 Feb 2017 | 9 Years 8 Months | Current |
| Falak Bagga | Director | 21 Aug 2021 | 5 Years 1 Months | Current |
Ownership and Shareholding of Purlin Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Purlin Pharma Private Limited
Purlin Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Purlin Pharma Private Limited
Employment history and EPFO contributions of people linked to Purlin Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Purlin Pharma Private Limited
Purlin Pharma Private Limited has 6 board changes on record since 2017: 2 appointments and 4 cessations. The latest: Deepika Chadha ceased to be Director on 13 Jan 2023.
Credit Ratings, Litigation & Regulatory Alerts for Purlin Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Purlin Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Purlin Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Purlin Pharma Private Limited
Purlin Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAICP5863F1ZC | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Purlin Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Purlin Pharma Private Limited
Purlin Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 May 2016 (10+ years old) and is registered under CIN U74999MP2016PTC040720.
Purlin Pharma reported revenue of ₹3.25 Lakh for FY 2024 (down 47% YoY).
Purlin Pharma has 2 current directors:
- Gaurav Bagga - Director
- Falak Bagga - Director
Purlin Pharma reported a net loss of ₹2,155 (net margin -0.7%) and EBITDA of ₹5,098 (EBITDA margin 1.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Purlin Pharma is -59% over three years and -46% over five years. In the latest year (FY 2024) revenue fell 47%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Purlin Pharma is 23AAICP5863F1ZC, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Purlin Pharma is U74999MP2016PTC040720. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Purlin Pharma was incorporated on 11 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Purlin Pharma by revenue are Dr. Kpr's Labs Private Limited, Audiunt Hearing Solution Private Limited, Sumati Diagnostics Private Limited, Oreal Healthcare & Wellness Private Limited, Medi One Pharma Labs Private Limited and 5 more, all in the same principal business activity (Medical and dental practice, Nursing, pathology, blood bank services, etc.).
Deepika Chadha ceased to be Director on 13 Jan 2023. Navin Chadha ceased to be Director on 13 Jan 2023. Falak Bagga ceased to be Additional Director on 30 Nov 2021. Purlin Pharma has 6 board changes on record in total.
The registered office of Purlin Pharma is at 307 Princes Business Sky Line Block 32&33 Scheme No. 54 Vijay Nagar, A.B. Road, Indore, Madhya Pradesh, India – 452010.